HomeBLSIF • OTCMKTS
add
Britannia Life Sciences Inc
Previous close
$0.060
Year range
$0.030 - $0.080
Market cap
14.60M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 65.36K | -61.16% |
Operating expense | 415.70K | -39.15% |
Net income | 12.13M | 8,962.04% |
Net profit margin | 18.56K | 22,914.89% |
Earnings per share | — | — |
EBITDA | -364.06K | 39.91% |
Effective tax rate | 13.38% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.89M | 1,504.04% |
Total assets | 22.06M | -0.48% |
Total liabilities | 4.83M | -70.42% |
Total equity | 17.23M | — |
Shares outstanding | 162.25M | — |
Price to book | 0.55 | — |
Return on assets | -5.86% | — |
Return on capital | -7.60% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 12.13M | 8,962.04% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2000
Headquarters
Website
Employees
28
